Serum is not required for ex vivo IFN-γ ELISPOT: a collaborative study of different protocols from the European CIMT Immunoguiding Program

The Cancer Immunotherapy Immunoguiding Program has conducted an IFN-γ ELISPOT proficiency panel to examine the influence of serum supplementation of test media on assay performance. Sixteen European laboratories analyzed the same PBMC samples using different locally established protocols. Participan...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Mander, A., Gouttefangeas, C., Ottensmeier, C., Welters, M. J. P., Low, L., van der Burg, S. H., Britten, C. M.
Format: Artigo
Jezik:Inglês
Izdano: Springer-Verlag 2010
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2813523/
https://ncbi.nlm.nih.gov/pubmed/20052465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-009-0814-4
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items